Lulu Wang

GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease

Rohit Loomba, Zeid Kayali, Mazen Noureddin et al. · Gastroenterology · 2018 · 329 citations · Full text

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +12

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials

Quentin M. Anstee, Eric Lawitz, Naim Alkhouri et al. · Hepatology · 2019 · 258 citations

Gut-Derived Serotonin Contributes to the Progression of Non-Alcoholic Steatohepatitis via the Liver HTR2A/PPARγ2 Pathway

Lulu Wang, Xiangcheng Fan, Jichun Han et al. · Frontiers in Pharmacology · 2020 · 30 citations · Full text

Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials

Vincent Wai‐Sun Wong, Won Young Tak, George Boon‐Bee Goh et al. · Clinical Gastroenterology and Hepatology · 2022 · 26 citations · Full text

Prebiotic-like cyclodextrin assisted silybin on NAFLD through restoring liver and gut homeostasis

Ling Ren, Xiaolei Ma, Hongliang Wang et al. · Journal of Controlled Release · 2022 · 26 citations

Hepatology, Biochemistry, Medicine +7